Published in J Gen Virol on October 01, 1999
The DC receptor DNGR-1 mediates cross-priming of CTLs during vaccinia virus infection in mice. J Clin Invest (2012) 1.52
Vaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7. PLoS Pathog (2011) 1.22
Poxvirus targeting of E3 ligase β-TrCP by molecular mimicry: a mechanism to inhibit NF-κB activation and promote immune evasion and virulence. PLoS Pathog (2013) 1.08
CD11b⁺, Ly6G⁺ cells produce type I interferon and exhibit tissue protective properties following peripheral virus infection. PLoS Pathog (2011) 1.05
Analysis of A47, an immunoprevalent protein of vaccinia virus, leads to a reevaluation of the total antiviral CD8+ T cell response. J Virol (2010) 1.01
The vaccinia virus superoxide dismutase-like protein (A45R) is a virion component that is nonessential for virus replication. J Virol (2001) 1.00
Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens. Virology (2007) 1.00
Vaccinia virus protein C4 inhibits NF-κB activation and promotes virus virulence. J Gen Virol (2012) 0.97
Camelpox virus encodes a schlafen-like protein that affects orthopoxvirus virulence. J Gen Virol (2007) 0.93
Vaccinia virus protein N2 is a nuclear IRF3 inhibitor that promotes virulence. J Gen Virol (2013) 0.90
Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence. J Gen Virol (2008) 0.89
The Vaccinia virus complement control protein modulates adaptive immune responses during infection. J Virol (2010) 0.88
Immunodomination during peripheral vaccinia virus infection. PLoS Pathog (2013) 0.87
Vaccinia virus lacking the Bcl-2-like protein N1 induces a stronger natural killer cell response to infection. J Gen Virol (2008) 0.86
Vaccinia virus protein K7 is a virulence factor that alters the acute immune response to infection. J Gen Virol (2013) 0.86
Deletion of immunomodulator C6 from vaccinia virus strain Western Reserve enhances virus immunogenicity and vaccine efficacy. J Gen Virol (2013) 0.86
N-ras couples antigen receptor signaling to Eomesodermin and to functional CD8+ T cell memory but not to effector differentiation. J Exp Med (2013) 0.85
Comparable polyfunctionality of ectromelia virus- and vaccinia virus-specific murine T cells despite markedly different in vivo replication and pathogenicity. J Virol (2012) 0.84
Poxvirus complement control proteins are expressed on the cell surface through an intermolecular disulfide bridge with the viral A56 protein. J Virol (2010) 0.83
Dermal-resident versus recruited γδ T cell response to cutaneous vaccinia virus infection. J Immunol (2015) 0.83
Mutations in modified virus Ankara protein 183 render it a non-functional counterpart of B14, an inhibitor of nuclear factor kappaB activation. J Gen Virol (2010) 0.80
Systemic toll-like receptor ligation and selective killing of dendritic cell subsets fail to dissect priming pathways for anti-vaccinia virus CD8⁺ T cells. J Virol (2013) 0.78
Impact of distinct poxvirus infections on the specificities and functionalities of CD4+ T cell responses. J Virol (2014) 0.77
Inhibition of Translation Initiation by Protein 169: A Vaccinia Virus Strategy to Suppress Innate and Adaptive Immunity and Alter Virus Virulence. PLoS Pathog (2015) 0.77
Enhancement of CD8(+) T-cell memory by removal of a vaccinia virus nuclear factor-κB inhibitor. Immunology (2015) 0.77
Extent of Systemic Spread Determines CD8+ T Cell Immunodominance for Laboratory Strains, Smallpox Vaccines, and Zoonotic Isolates of Vaccinia Virus. J Immunol (2015) 0.77
Vaccinia virus A43R gene encodes an orthopoxvirus-specific late non-virion type-1 membrane protein that is dispensable for replication but enhances intradermal lesion formation. Virology (2009) 0.76
MyD88-dependent immunity to a natural model of vaccinia virus infection does not involve Toll-like receptor 2. J Virol (2014) 0.76
Deletion of the K1L Gene Results in a Vaccinia Virus That Is Less Pathogenic Due to Muted Innate Immune Responses, yet Still Elicits Protective Immunity. J Virol (2017) 0.75
Increased attenuation but decreased immunogenicity by deletion of multiple vaccinia virus immunomodulators. Vaccine (2016) 0.75
Both CD8+ and CD4+ T Cells Contribute to Corneal Clouding and Viral Clearance following Vaccinia Virus Infection in C57BL/6 Mice. J Virol (2016) 0.75
CD4(+) T-cell dependence of primary CD8(+) T-cell response against vaccinia virus depends upon route of infection and viral dose. Cell Mol Immunol (2014) 0.75
Ectopic expression of vaccinia virus E3 and K3 cannot rescue ectromelia virus replication in rabbit RK13 cells. PLoS One (2015) 0.75
General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J Virol (1984) 10.98
Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proc Natl Acad Sci U S A (1982) 7.81
Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. Proc Natl Acad Sci U S A (1985) 5.42
Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature (1983) 5.25
Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters. Proc Natl Acad Sci U S A (1983) 4.69
Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat Med (1998) 4.13
Infectious poxvirus vectors have capacity for at least 25 000 base pairs of foreign DNA. Gene (1983) 3.94
A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc Natl Acad Sci U S A (2000) 3.69
Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature (1985) 3.62
Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell (1995) 3.51
A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell (1992) 3.36
Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells. Nature (1984) 3.21
Live recombinant vaccinia virus protects chimpanzees against hepatitis B. Nature (1984) 3.03
Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus. Virology (1994) 2.89
The effects of metabolic inhibition on intracellular calcium and pH in isolated rat ventricular cells. J Physiol (1989) 2.86
Vaccinia virus expression vectors. J Gen Virol (1986) 2.84
Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses. J Exp Med (1988) 2.73
A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope. Virology (1992) 2.67
The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence. Virology (1993) 2.66
Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine. J Gen Virol (1998) 2.55
IPTG-dependent vaccinia virus: identification of a virus protein enabling virion envelopment by Golgi membrane and egress. Nucleic Acids Res (1990) 2.41
Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress. J Virol (1992) 2.35
Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein. Science (1987) 2.24
Vaccinia virus intracellular mature virions contain only one lipid membrane. J Virol (1999) 2.24
Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes. J Gen Virol (1986) 2.16
Intracellular and extracellular vaccinia virions enter cells by different mechanisms. J Gen Virol (1998) 2.14
Vaccinia virus utilizes microtubules for movement to the cell surface. J Cell Biol (2001) 2.10
The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN. J Virol (2000) 2.08
Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity. J Virol (1995) 2.07
EGTA purity and the buffering of calcium ions in physiological solutions. Am J Physiol (1984) 2.03
Transient inhibition of polyoma virus synthesis by Sendai virus (parainfluenza I). I. Demonstration and nature of the inhibition by inactivated virus. J Virol (1972) 2.01
Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus. J Virol (1996) 2.01
Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. Proc Natl Acad Sci U S A (1998) 1.97
Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. J Immunol (1998) 1.94
A novel virus binding assay using confocal microscopy: demonstration that the intracellular and extracellular vaccinia virions bind to different cellular receptors. J Virol (1997) 1.86
Roles of vaccinia virus EEV-specific proteins in intracellular actin tail formation and low pH-induced cell-cell fusion. J Gen Virol (1998) 1.81
K201 modulates excitation-contraction coupling and spontaneous Ca2+ release in normal adult rabbit ventricular cardiomyocytes. Cardiovasc Res (2007) 1.76
Inducible gene expression from vaccinia virus vectors. Virology (1990) 1.76
Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime. Vaccine (1998) 1.74
Hepatitis B virus large surface protein is not secreted but is immunogenic when selectively expressed by recombinant vaccinia virus. J Virol (1986) 1.73
Inverse relation between prostate-specific antigen and insulin-like growth factor-binding protein 3 in bone metastases and serum of patients with prostate cancer. Lancet (1999) 1.70
Interactions between vaccinia virus IEV membrane proteins and their roles in IEV assembly and actin tail formation. J Virol (1999) 1.68
Cytokine receptors encoded by poxviruses: a lesson in cytokine biology. Immunol Today (1995) 1.68
Comparative risks and costs of male and female sterilization. Am J Public Health (1985) 1.65
Potentiometric measurements of stoichiometric and apparent affinity constants of EGTA for protons and divalent ions including calcium. Biochim Biophys Acta (1985) 1.65
Recognition of cloned influenza virus hemagglutinin gene products by cytotoxic T lymphocytes. J Virol (1986) 1.62
Production and characterisation of a monoclonal antibody to human papillomavirus type 16 using recombinant vaccinia virus. J Clin Pathol (1990) 1.57
Calcium-induced calcium release activates contraction in intact cardiac cells. Pflugers Arch (1989) 1.57
The vaccinia virus A36R protein is a type Ib membrane protein present on intracellular but not extracellular enveloped virus particles. Virology (2000) 1.56
Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1beta-converting enzyme and protects virus-infected cells from TNF- and Fas-mediated apoptosis, but does not prevent IL-1beta-induced fever. J Gen Virol (1997) 1.54
The vaccinia virus A27L protein is needed for the microtubule-dependent transport of intracellular mature virus particles. J Gen Virol (2000) 1.52
Vaccinia virus gene B1R encodes a 34-kDa serine/threonine protein kinase that localizes in cytoplasmic factories and is packaged into virions. Virology (1992) 1.50
Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation. J Gen Virol (1997) 1.49
The genome sequence of Yaba-like disease virus, a yatapoxvirus. Virology (2001) 1.48
The influence of tackle parameters on the propensity for injury in international football. Am J Sports Med (2004) 1.47
Lack of HIV infection and condom use in licensed prostitutes. Lancet (1986) 1.46
Vaccinia virus strains Lister, USSR and Evans express soluble and cell-surface tumour necrosis factor receptors. J Gen Virol (1999) 1.46
Preliminary studies of absorption and excretion of benoxaprofen in man. Br J Clin Pharmacol (1977) 1.46
Replication of the influenza virus genome. Virology (1982) 1.45
Plasmodium knowlesi sporozoite antigen: expression by infectious recombinant vaccinia virus. Science (1984) 1.42
S100A1: a regulator of myocardial contractility. Proc Natl Acad Sci U S A (2001) 1.42
Testicular prosthesis placement: a new technique. BJU Int (1999) 1.40
A mechanism for the inhibition of fever by a virus. Proc Natl Acad Sci U S A (1996) 1.39
Field evaluation of Haemophilus somnus bacterin. Vet Med Small Anim Clin (1977) 1.38
Vaccinia virus F12L protein is required for actin tail formation, normal plaque size, and virulence. J Virol (2000) 1.38
Circumcision as a risk factor for urethritis in racial groups. Am J Public Health (1987) 1.38
The relationship between intracellular calcium and contraction in calcium-overloaded ferret papillary muscles. J Physiol (1985) 1.37
Purified multiplication-stimulating activity from rat liver cell conditioned medium: comparison of biological activities with calf serum, insulin, and somatomedin. J Cell Physiol (1974) 1.37
Difficulties encountered in the search for the etiologic agents of destructive periodontal diseases. J Clin Periodontol (1987) 1.35
Vaccinia virus serpins B13R (SPI-2) and B22R (SPI-1) encode M(r) 38.5 and 40K, intracellular polypeptides that do not affect virus virulence in a murine intranasal model. Virology (1995) 1.34
The PA influenza virus polymerase subunit is a phosphorylated protein. J Gen Virol (1998) 1.33
Antibody neutralization of the extracellular enveloped form of vaccinia virus. Virology (2001) 1.32
Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice. J Gen Virol (1998) 1.32
Simultaneous measurements of action potential duration and intracellular ATP in isolated ferret hearts exposed to cyanide. Circ Res (1989) 1.31
Anchoring a secreted plasmodium antigen on the surface of recombinant vaccinia virus-infected cells increases its immunogenicity. Mol Cell Biol (1986) 1.31
An evaluation of direct access radiology in general practice. J R Coll Gen Pract (1979) 1.31
Metabolic consequences of increasing intracellular calcium and force production in perfused ferret hearts. J Physiol (1986) 1.30
Immunogenicity of a Haemophilus somnus bacterin in cattle. Am J Vet Res (1978) 1.27
The electrophysiological and mechanical effects of 2,3-butane-dione monoxime and cytochalasin-D in the Langendorff perfused rabbit heart. Exp Physiol (2004) 1.25
Clinical performance of a rule-based decision support system for mechanical ventilation of ARDS patients. Proc Annu Symp Comput Appl Med Care (1993) 1.23
The extracellular domain of vaccinia virus protein B5R affects plaque phenotype, extracellular enveloped virus release, and intracellular actin tail formation. J Virol (1998) 1.23
Virus-induced cell motility. J Virol (1998) 1.23
Overexpression of FK506-binding protein FKBP12.6 in cardiomyocytes reduces ryanodine receptor-mediated Ca(2+) leak from the sarcoplasmic reticulum and increases contractility. Circ Res (2001) 1.21
Nucleotide sequence of 21.8 kbp of variola major virus strain Harvey and comparison with vaccinia virus. J Gen Virol (1992) 1.20
Vaccinia virus encodes an active thymidylate kinase that complements a cdc8 mutant of Saccharomyces cerevisiae. J Biol Chem (1991) 1.20
A vaccinia serine protease inhibitor which prevents virus-induced cell fusion. J Gen Virol (1992) 1.20
Vaccinia virus core protein VP8 is required for virus infectivity, but not for core protein processing or for INV and EEV formation. Virology (1994) 1.20
The contribution of intracellular acidosis to the decline of developed pressure in ferret hearts exposed to cyanide. J Physiol (1987) 1.20
Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma. J Clin Oncol (2000) 1.19
Rapid method for the purification of DNA from subgingival microorganisms. Oral Microbiol Immunol (1989) 1.19
The mechanism of early contractile failure of isolated rat ventricular myocytes subjected to complete metabolic inhibition. J Physiol (1989) 1.19
Metabolic changes during ischaemia and their role in contractile failure in isolated ferret hearts. J Physiol (1992) 1.19
Vaccinia DNA ligase complements Saccharomyces cerevisiae cdc9, localizes in cytoplasmic factories and affects virulence and virus sensitivity to DNA damaging agents. EMBO J (1991) 1.19
Heterogeneous changes in action potential and intracellular Ca2+ in left ventricular myocyte sub-types from rabbits with heart failure. Cardiovasc Res (2000) 1.19
The effects of 2,3-butanedione monoxime on initial heat, tension, and aequorin light output of ferret papillary muscles. Pflugers Arch (1990) 1.19
Vaccinia virus homologues of the Shope fibroma virus inverted terminal repeat proteins and a discontinuous ORF related to the tumor necrosis factor receptor family. Virology (1991) 1.18
Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival. Br J Cancer (2000) 1.17